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Sphingosine-1-phosphate (S1P) is emerging as a new class of second messenger in-
volved in cellular proliferation, differentiation, and apoptosis and is implicated in di-
verse physiological functions. Despite many studies on the biological functions of S1P, 
however, little is known about its role in neuronal differentiation. By use of reverse 
transcription-polymerase chain reaction and immunostaining, this study aimed to ex-
plore whether S1P can differentiate neuroblastoma cells into neural cells. After in-
cubation with 1 uM or 10 uM S1P, the number of neurite-bearing cells increased. 
Furthermore, the neuroblastoma cells revealed immunoreactivity for neural-specific 
markers such as GAP43, NFH, and SYP by immunostaining. The expression of NFH, 
MAP2, SYP, NeuroD1, and SYT mRNA, which is specific for neurons, was increased 
as shown by RT-PCR studies. The results of this study suggest that that S1P can induce 
neuronal differentiation and may be a good candidate for the treatment of neuro-
degenerative diseases.
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INTRODUCTION
　Sphingosine-1-phosphate (S1P) is derived from sphingo-
sine, the backbone of most sphingolipids, and is now emerg-
ing as a vital lipid mediator.
1 S1P is one of a new class of 
second messengers involved in cellular proliferation, dif-
ferentiation, and apoptosis and implicated in diverse phys-
iological functions, including immune modulation, vas-
cular and nervous system development, regulation of 
smooth muscle, and auditory and vestibular function.
1-4 
　Intermediates in the biosynthesis and catabolism of 
sphingolipids, ceramide, sphingosine, and S1P have re-
cently been implicated in the intracellular signaling im-
portant for neuronal survival, differentiation, develop-
ment, and death. Because increased levels of ceramide 
were observed during differentiation of neuroblastoma 
Neuro2a cells and SH-SY5Y cells, it has been suggested 
that ceramide plays a role in neuronal differentiation.
2,5,6 
Also, S1P was recently shown to be a key regulator of pro-
liferation and differentiation by up-regulating sphingo-
sine kinase expression in retina photoreceptors.
7
　Neuroblastomas derived from immature sympathetic 
ganglionic cells are arrested at various stages of differen-
tiation.
8 Differentiation studies have revealed that neuro-
blastoma cell lines can be induced to differentiate in the 
presence of various agents and growth factors. At first, hu-
man SH-SY5Y neuroblastoma cells (a subclone of the SK- 
N-SH cell line) were reported to differentiate morphologi-
cally and biochemically in response to bioactive phorbole-
sters.
9
　Despite many studies concerning the physiologic actions 
of S1P, little is known about its capacity to differentiate 
neurons. This study intended to explore the differentiating 
action of S1P by using neuroblastoma cell lines. In this 
study, S1P induced neuronal differentiation in neuro-
blasoma cells. 
MATERIALS AND METHODS
1. Cell culture and treatment
　SH-SY5Y human neuroblastoma cells (ATCC number: 
CRL-2266
TM) capable of differentiation to neuronal cells 
under specific conditions were cultured in DMEM (Hyclone, 
Logan, UT, USA) containing 10% fetal bovine serum (Hy-28
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FIG. 1.  Effects of S1P on the number of neurite-bearing cells. After
incubation with S1P, neuroblastoma cells revealed morphological
changes with neurite outgrowth (top), and the number of neu-
rite-bearing cells was increased dose-dependently (bottom). 
Magnification is 10×10. Statistical significance is *p＜0.05.
clone) and 1% penicillin-streptomycin (Hyclone). The cells 
were grown to approximately 80% confluence in a 37
oC hu-
midified incubator in an environment of 5% CO2 and 95% 
air and were then harvested in trypsin containing EDTA 
(Hyclone). Sphingosine-1-phosphate (Sigma Chemical Co., 
St. Louis, MO, USA) was initially dissolved and diluted to 
a final stock concentration of 10 mM in water before use. 
The SH-SY5Y neuroblastoma cells were differentiated for 
3 or 4 days in the presence of 1 or 10 uM S1P.
2. Analysis of neurite outgrowth
　The cells were grown under conditions with S1P for 4 
days. The morphology of the SH-SY5Y cells was investigated 
with a NiKon phase-contrast inverted microscope equip-
ped with a Nikon Coolpix 4500 high-resolution camera. 
Changes in neurite length were observed over 4 days, and 
the medium was replaced every 2 days. A total of 200 to 300 
cells were microscopically evaluated and scored for neurite 
formation by use of the Image J program if they had a neu-
rite that was longer than one cell diameter or had a growth 
cone. All experiments were repeated at least three times 
with similar results.
3. Reverse transcription-polymerase chain reaction 
(RT-PCR) 
　Cells were cultured in 6-well plates as described pre-
viously. Total RNA was extracted from the cultured cells 
by using the Tri Reagent (Molecular Research Center Inc., 
Cincinnati, OH, USA) isolation reagent. cDNA was synthe-
sized by reverse transcription with M-MLV reverse tran-
scriptase (Gibco BRL, Grand Island, NY, USA) and 1 mmol 
total RNA. The cDNA was amplified by 25 to 35 cycles of 
PCR (Takara Bio Inc., Shiga, Japan) with Ex-Taq polymer-
ase (Takara Bio Inc.). The primers (Bioneer Co., Daejeon, 
Korea) used were chosen and checked for specificity by us-
ing a basic BLAST search. The RT-PCR products were sep-
arated electrophoretically on 2% agarose gels. We used the 
following primer pairs (gene, forward, reverse, and cDNA 
product length): 5’-AAA TCG CAT CCA GAT TTT C-3’, 
5’-CAC TGC CTC CTA GCT TGT C-3’, 316 bp; neurofila-
ment-H (NFH), 5’-CCG ACG ACA CCA AGC TCA-3’, 
5’-GGA ATG AAA CAG GGC GTT-3’, 336 bp; micro-
tubule-associated protein-2 (MAP-2), 5’-TGC CAT CTT 
GGT GCC GA-3’, 5’-CTT GAC ATT ACC ACC TCC AGG 
T-3’, 460 bp; synaptophysin (SYP), 5’-CTT CCT GCA GAA 
CAA GTA CC-3’, 5’-CTT AAA CAC GAA CCA CAG GT-3’, 
295 bp; neurogenic differentiation 1 (NeuroD1), 5’-CCG 
ACA GAG CCC AGA TGT AGT TCT T-3’, 5’-GCC CCA GGG 
TTA TGA GAC TAT CAC T-3’, 278 bp; synaptotagamin 
(SYT), 5’-CGC AAA CTG GGC AAA CGC TA-3’, 5’-GCA 
ACC CTC GTG GGC CTC-3’, 421 bp; GAPDH, 5’-CAT GAC 
CAC AGT CCA TGC CAT CAC T-3’, 5’-TGA GGT CCA CCA 
CCC TGT TGC TGT A-3’, and 461 bp.
4. Immunostaining 
　Immunochemical determination of neuronal differenti-
ated SH-SY5Y cells was performed as follows. The cells were 
grown on poly-D-lysine-coated aclar plastic coverslips for 
4 days in the presence of 10 mM S1P, fixed for 15 min with 
4% paraformaldehyde (Sigma Chemical Co.), permeabilized 
for 20 min with 0.3% Triton X-100 (Sigma Chemical Co.) 
including 10% normal goat serum (Vector Laboratories Inc., 
Burlingame, CA, USA) in phosphate-buffered saline, and 
incubated with antibodies specific for each antigen marker. 
The cultures incubated with primary antibodies were fol-
lowed by biotinylated secondary antibodies and avidin-biotin 
complex (Vector Laboratories Inc.). The cell type-specific 
markers used were growth associated protein-43 (GAP43), 
NFH, and SYP. The antibodies were purchased from Che-
micon (Chemicon, Temecula, CA, USA).
5. Statistics
　All values are expressed as means±SEMs. The one-way 
ANOVA test was used to analyze the differences between 
groups, with p＜0.05 being considered significant. 
RESULTS
1. Effects of S1P on neurite outgrowth in neuroblastoma 
cells
　After incubation with 1 uM or 10 uM S1P, the neuro-
blastoma cells revealed neurite outgrowth. The number of 
neurite-bearing cells increased from 14% to 37% and 28% 
by 1 uM S1P after 72 hours and 96 hours, respectively. The 
number of neurite-bearing cells increased from 14% to 18% 
and 46% by 10 uM S1P after 72 hours and 96 hours, re-
spectively (Fig. 1).29
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FIG. 2.  Immunocytochemical staining 
for neuron-specific markers in differen-
tiated cells by S1P. Neuroblastoma cells
were induced to differentiate into neu-
ronal cells in the presence of S1P. Immu-
nocytochemistry revealed that the ex-
pression of neuron-specific markers 
such as GAP43, NFH, and SYP was in-
creased. Scale bar represents 50 μm 
(10×10).
FIG. 3.  RT-PCR analysis of neuronal markers in differentiated
cells. The expression of NFH, MAP2, SYP, NeuroD1, and SYT 
mRNA, which is specific for neurons, was increased by treatment
with S1P. GAPDH was used as a control.
2. Effects of S1P on the immunoreactivity for neuron- 
specific markers in neuroblastoma cells 
　After incubation with S1P, the neuroblasoma cells re-
vealed immunoreactivity for neural-specific markers. The 
neuronal cells were positive for neuronal markers such as 
GAP43, NFH, and SYP (Fig. 2). 
3. Effects of S1P on the expression of neuronal gene markers
　Reverse transcription-polymerase chain reaction was 
used to examine the expression of mRNA related to neuro-
nal differentiation. The expression of NFH, Ngn1, MAP2, 
SYP, NeuroD1, and SYT mRNA, which is specific for neu-
rons, was increased by treatment with S1P (Fig. 3). 
DISCUSSION
　Neuronal differentiation and cellular homeostasis are 
fundamental events in the development of the nervous sys-
tem as well as in the regeneration of damaged nervous 
tissue. Differentiation is regulated by a complex mecha-
nism, in which the result of several interactions between 
the cell and the extracellular medium determines the fate 
of the cellular function.
10
　S1P is known to induce differentiations in various cell 
types. It stimulates differentiation of adipose tissue-de-
rived mesenchymal stem cells towards smooth muscle 
cells. It increases the expression of smooth muscle cell-spe-
cific proteins such as alpha-smooth muscle actin (alpha 
SMA) and transgelin.
11 Sphingosine kinase, which pro-
motes the formation of S1P, enhances the expression of myo-
genic differentiation markers in myoblasts.
12 Recently, 
Miranda et al proposed S1P as a key regulator in the devel-
opment of photoreceptors. It increases the proliferation of 
photoreceptor progenitors and increases the formation of 
apical processes and enhances the expression of opsin and 
peripherin in photoreceptors.
13
　Despite their tumoral origin, neuroblastoma cell lines 
can be induced to differentiate in vitro by several agents.
14 
In this work, we used the SH-SY5Y neuroblastoma cell line, 
which showed homogeneous populations of differentiated 
cells due to STP or retinoic acid.
15 Retinoic acids are natural 
and synthetic derivatives of vitamin A that, together with 
their nuclear control genetic programs, are essential for 
embryonic development, organ homeostasis, cell growth, 
differentiation, and apoptosis.
16
　We observed that treatment with S1P for 4 days induced 
neuronal morphological changes in neuroblastoma cells, 
which were similar to those described by other authors.
15,16 
To confirm that the morphological changes observed ac-
tually resulted from the neuronal differentiation, the ex-
pression of several neuronal markers was explored. We ob-
served that the typical morphological feature of differ-
entiation was accompanied by biochemical changes. In the 
present study, S1P induced immunoreactivities for neuro-
nal markers and increased the expression of neuronal gene 
markers in neuroblastoma cells. 
　Intermediates in the biosynthesis and catabolism of 
sphingolipids, ceramide, sphingosine, and S1P have recen-
tly been implicated in intracellular signaling important for 
neuronal survival, differentiation, development, and death. 
S1P is emerging as a new class of second messenger involved 
in cellular proliferation, differentiation, and apoptosis.
2 30
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The above experimental results imply that S1P could be 
used to differentiate neuronal cells and may be a good can-
didate for the treatment of neurodegenerative diseases.
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